Among PSMA ligands boasting high affinity for their extracellular domain, piflufolastat labeled with 18F (18F-DCFPyL) has been extensively investigated, demonstrating superior performance for the staging and re-staging of PC over traditional imaging modalities in the OSPREY and CONDOR clinical trials [103,104]. Here, FOLH1 is linked to pachyonychia congenita.